Criteria of a successful coasting protocol for the prevention of severe ovarian hyperstimulation syndrome

Human Reproduction

Volumn 20, Issue 11, 2005, Pages 3167-3172

  Mansour, Ragaa ^a   Aboulghar, Mohamed ^a   Serour, Gamal ^a   Amin, Yehia ^a   Abou Setta, Ahmed M ^a  

^a EGYPTIAN IVF ET CENTER   (Egypt)

Author keywords

Assisted reproductive technology; Coasting ovarian hyperstimulation syndrome; Ovulation induction; Prevention

Indexed keywords

CHORIONIC GONADOTROPIN; ESTRADIOL; HUMAN MENOPAUSAL GONADOTROPIN;

ADULT; ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; DISEASE SEVERITY; EMBRYO TRANSFER; ESTRADIOL BLOOD LEVEL; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HIGH RISK POPULATION; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; MAJOR CLINICAL STUDY; OOCYTE; OVARY DISEASE; PREGNANCY RATE; RETROSPECTIVE STUDY; RISK ASSESSMENT; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

EID: 27944472722     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/dei180     Document Type: Article

References (44)

1. Abdalla HI, Ah-Moye M, Brinsden P, Howe DL, Okonfua F and Craft I (1987) The effect of the dose of hCG and the typed gonadotropin stimulation on oocyte recovery rates in an IVF program. Fertil Steril 48,958-963.
2. Aboulghar MA and Mansour RT (2003) Ovarian hyperstimulation syndrome: classifications and critical analysis of preventive measures. Hum Reprod Update 3,275-89.
3. Aboulghar MA, Mansour RT, Serour GI, Sattar M, Amin Y and Elattar I (1993) Management of severe ovarian hyperstimulation syndrome by ascetic fluid aspiration and intensive intravenous fluid therapy. Obstet Gynecol 81,108-111.
4. Aboulghar MA, Mansour RT, Serour GI, Rhodes CA and Amin YM (2000) Reduction of human menopausal gonadotrophin dose followed by coasting in prevention of severe ovarian hyperstimulation syndrome. J Assist Reprod Genet 17,298-301.
5. Al-Shawaf T, Zosmer A, Hussain S, Tozer A, Panay N, Wilson C, Lower AM and Grudzinkas JG (2001) Prevention of severe ovarian hyperstimulation syndrome in IVF with or without ICSI and embryo transfer: A modified coasting strategy based on ultrasound for identification of high-risk patients. Hum Reprod 16,24-30.
6. Al-Shawaf T, Zosmer A, Tozer A, Gillott C, Lower AM and Grudzinskas JG (2002) Value of measuring serum FSH in addition to serum estradiol in a coasting programme to prevent severe OHSS. Hum Reprod 17,1217-1221.
7. Asch RH, Ivery G, Goldsman M, Frederick JL, Stone SC and Balmaceda JP (1993) The use of intravenous albumin in patients at high risk for severe ovarian hyperstimulation syndrome. Hum Reprod 8,1015-1020.
8. Awonuga AO, Pittrof RJ, Zaidi J, Dean N, Jacobe HS, Benadiva CA, Davis O, Kligman I, Moomjy M, Liu H-C and Rosenwaks Z (1997) Withholding gonadotrophin administration is an effective alternative for the prevention of ovarian hyperstimulation syndrome. Fertil Steril 67,724-727.
9. Benadiva CA, Davis O, Kligman I, Moomjy M, Liu H-C and Rosenwaks Z (1997) Withholding gonadotrophin administration is an effective alternative for the prevention of ovarian hyperstimulation syndrome. Fertil Steril 67,724-727.
10. Ben-Nun I, Shulman A, Ghetler Y, Shilon M, Maneti H and Beyth Y (1993) The significance of 17β-estradiol levels in highly responding women during ovulation induction in IVF treatment: Its impact and prognostic value with respect to oocyte maturation and treatment outcome. J Assist Reprod Genet 10,213-215.
11. Bider D, Menashe Y, Oelsner G, Serr DM, Mashiach S and Ben-Rafael Z (1989) Ovarian hyperstimulation due to exogenous gonadotrophin administration. Acta Obstet Gynecol Scand 68,511-514.
12. Bornestein R, Elhalah U, Lunenfeld B and Schwartz ZS (1989) Severe ovarian hyperstimulation syndrome: A reevaluated therapeutic approach. Fertil Steril 51,791-795.
13. Child TJ, Phillips SJ, Abdul-Jalil AK, Gulekli B and Tan SL (2002) A comparison of in vitro maturation and in vitro fertilization for women with polycystic ovaries. Obstet Gynecol 100,665-670.
14. Chun S, Eisenhauer K, Minami S, Billig H, Perlas E and Hsueh A (1996) Hormonal regulation of apoptosis in early astral follicles: follicle-stimulating hormone as a major survival factor. Endocinology 137,1447-1456.
15. Delvigne A and Rozenberg S (2001) Preventive attitude of physicians to avoid OHSS in IVF patients. Hum Reprod 16,2491-2495.
16. Delvigne A and Rozenberg S (2002a) Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): A review. Hum Reprod Update 8,559-577.
17. Delvigne A and Rozenberg S (2002b) A qualitative systematic review of coasting, a procedure to avoid ovarian hyperstimulation syndrome in IVF patients. Hum Reprod Update 8,291-296.
18. Dhont M, Van der Straeten F and De Sutter P (1998) Prevention of severe ovarian hyperstimulation by coasting. Fertil Steril 70,847-850.
19. Egbase PE, Al Sharhan M and Grudzinskas JG (2002) Early coasting in patients with polycystic ovarian syndrome is consistent with good clinical outcome. Hum Reprod 17,1212-1216.
20. El-Sheikh MM, Hussein M, Fouad S, El-Sheikh R, Bauer O and Al-Hasani S (2001) Limited ovarian stimulation (LOS), prevents the recurrence of severe forms of ovarian hyperstimulation syndrome in polycystic ovarian disease. Eur J Obstet Gynecol Reprod Biol 94,245-249.
21. Filicori M, Cognini GE, Tabarelli C, Pocognoli P, Taraborrelli S, Spettoli D and Ciampaglia W (2002) Stimulation and growth of antral ovarian follicles by selective LH activity administration in women. J Clin Endocrinol Metab 87,1156-1161.
22. Fredhlander MA, De Mola JR and Goldfarb JM (1993) Elevated levels of interleukin 6 in ascites and serum from women with ovarian hyperstimulation syndrome. Fertil Steril 60,827.
23. Garcia-Velasco JA, Isaza V, Vidal C, Landazábal A, Remohi J, Simon C and Pellicer A (2004) Human ovarian steroid secretion in vivo: Effects of GnRH agonist versus antagonist (cetrorelix). Hum Reprod 16,2533-2539.
24. Golan A, Ron-El R, Herman A, Weinraub Z, Soffer Y and Caspi E (1988) Ovarian hyperstimulation syndrome following D-Trp-6 luteinising hormone releasing hormone microcapsules and menotrophin for in vitro fertilization. Fertil Steril 50,912-916.
25. Haning RV, Strawn EY and Nolten WE (1985) Pathophysiology of ovarian hyperstimulation syndrome. Obstet Gynecol 66,220-224.
26. Isaza V, Garcia-Velasco JA, Aragones M, Remhi J, Simon C and Pellicer A (2002) Oocyte and embryo quality after coasting: The experience from oocyte donation. Hum Reprod 17,1777-1782.
27. Lee C, Tummon I, Martin J, Nisker J, Power S and Tekpetey F (1998) Does withholding gonadotrophin administration prevent severe ovarian hyperstimulation syndrome? Hum Reprod 13,1157-1158.
28. Macklon NS and Fauser BC (2000) Gonadotropin therapy for the treatment of anovulation and for ovarian hyperstimulation for IVF. Mol Cell Endocrinol 55,159-161.
29. Mansour RT, Aboulghar MA, Serour GI, Fahmy I, Ramzi AM and Amin YM (1996) Intracytoplasmic sperm injection using microsurgically retrieved epididymal sperms and testicular sperm. Fertil Steril 95,566-572.
30. Mclure N, Healy D, Rogerrs P, Sullivan J, Beaton L, Haning RV Jr, Conolly D and Robertson DM (1994) Vascular endothelial growth factors as capillary permeability agent in ovarian hyperstimulation. Lancet 344,236.
31. Meldrum D (2002) Vascular endothelia growth factor, polycystic ovary syndrome, and ovarian hyperstimulation syndrome. Fertil Steril 78,1170-1171.
32. Navot D, Bergh PA and Laufer N (1992) Ovarian hyperstimulation syndrome in novel reproductive technologies: Prevention and treatment. Fertil Steril 58,249-261.
33. Ohata Y, Harada T, Ito M Yoshida S, Iwabe T and Terakawa N (2000) Coasting may reduce the severity of the ovarian hyperstimulation syndrome in patients with polycystic ovary syndrome. Gynecol Obstet Invest 50,186-188.
34. Rabinovici J, Kushnir O, Shalev J, Goldenberg M and Blankstein J (1987) Rescue of menotropin cycles prone to develop ovarian hyperstimulation. Br J Obstet Gynecol 94,1098-1102.
35. Rizk B and Aboulghar MA (1999) Classification, pathophysiology, and management of ovarian hyperstimulation syndrome. In Brinsden P (ed) In-Vitro Fertilization and Assisted Reproduction. Parthenon Publishing, New York/London, pp 131-155.
36. Rizk B and Smitz J (1992) Ovarian hyperstimulation syndrome after superovulation for IVF and related procedures. Hum Reprod 7,320-327.
37. Serour GI, Aboulghar M, Mansour R, Sattar MA, Amin Y and Aboulghar H (1998) Complications of medically assisted conception in 3,500 cycles. Fertil Steril 4,638-642.
38. Sher G, Salem R, Feinman M, Dodge S, Zouves C and Knotzen V (1993) Eliminating the risk of life-endangering complications following overstimulation with menotropin fertility agents: A report on women undergoing in vitro fertilization and embryo transfer. Obstet Gynecol 81,1009-1011.
39. Sher G, Zouves C, Feinman M and Maassarani G (1995) Prolonged coasting: an effective method for preventing severe ovarian hyperstimulation syndrome in patients undergoing in-vitro fertilization. Hum Reprod 10,3107-3109.
40. Tortoriello DV, McGovern PG, Colon JM, Skurnick JH, Lipetz K and Santoro N (1998) "Coasting" does not adversely affect cycle outcome in a subset of highly responsive in vitro fertilization patients. Fertil Steril 69,454-460.
41. Ulug U, Ben-Shlomo I and Bahceci M (2004) Predictors of success during the coasting period in high-responder patients undergoing controlled ovarian stimulation for assisted conception. Fertil Steril 82,338-342.
42. Urman B, Pride SM and Ho Yuen B (1992) Management of overstimulated gonadotrophin cycles with a controlled drift period. Hum Reprod 7,213-217.
43. Waldenstrom U, Kahn J, Marsk L and Nilsson S (1999) High pregnancy rates and successful prevention of severe ovarian hyperstimulation syndrome by prolonged coasting of very hyperstimulated patients: A multicentre, study. Hum Reprod 14,294-247.
44. Wheelan JG III and Vlahos NF (2000) The ovarian hyperstimulation syndrome. Fertil Steril 73,883-896.